Continuous subcutaneous carbidopa improves levodopa pharmacokinetics in Parkinson's disease patients

被引：0
|
作者：
Caraco, Y.
Giladi, N.
Oren, S.
LeWitt, P. A.
机构：
来源：
MOVEMENT DISORDERS | 2012年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
349
引用
收藏
页码：S111 / S111
页数：1
相关论文
共 50 条
  • [41] Carbidopa/Levodopa Pharmacy Errors in Parkinson's Disease
    Khadem, Nasim R.
    Nirenberg, Melissa J.
    NEUROLOGY, 2010, 74 (09) : A350 - A350
  • [42] New developments in continuous jejunal infusion of levodopa/carbidopa in advanced Parkinson's disease
    Moller, Jens Carsten
    Oechsner, Matthias
    Basal Ganglia, 2015, 5 (04) : 95 - 99
  • [43] Carbidopa/Levodopa Pharmacy Errors in Parkinson's Disease
    Khadem, Nasim R.
    Nirenberg, Melissa J.
    MOVEMENT DISORDERS, 2010, 25 (16) : 2867 - 2871
  • [44] Levodopa dose maintenance or reduction in patients with Parkinson's disease transitioning to levodopa/carbidopa/entacapone
    Park, Jongkyu
    Kim, Younsoo
    Youn, Jinyoung
    Lee, Phil H.
    Sohn, Young H.
    Koh, Seoung B.
    Lee, Jee-Young
    Baik, Jong S.
    Cho, Jin W.
    NEUROLOGY INDIA, 2017, 65 (04) : 746 - 751
  • [45] PHARMACOKINETICS OF CONTINUOUS-RELEASE CARBIDOPA/LEVODOPA
    SAGE, JI
    MARK, MH
    CLINICAL NEUROPHARMACOLOGY, 1994, 17 : S1 - S6
  • [46] Nanoencapsulation of Levodopa and Carbidopa for the Treatment of Parkinson's Disease
    Fan, Baochan
    Lamba, Sanvi
    Hu, Qiaobin
    Wang, Shu
    ANNALS OF NEUROLOGY, 2022, 92 : S118 - S119
  • [47] Pharmacokinetics and efficacy of a novel formulation of carbidopa-levodopa (Accordion Pill®) in Parkinson's disease
    LeWitt, Peter A.
    Giladi, Nir
    Navon, Nadav
    PARKINSONISM & RELATED DISORDERS, 2019, 65 : 131 - 138
  • [48] Pharmacokinetics and safety of concurrent donepezil HCl and levodopa/carbidopa administration in subjects with Parkinson's disease
    Okereke, CS
    Kumar, D
    Cullen, EI
    Pratt, RD
    Hahne, WF
    NEUROLOGY, 2001, 56 (08) : A457 - A457
  • [49] Levodopa–Carbidopa Intestinal Gel in Patients with Parkinson’s Disease: A Systematic Review
    Karin Wirdefeldt
    Per Odin
    Dag Nyholm
    CNS Drugs, 2016, 30 : 381 - 404
  • [50] Effects of One-Day Application of Levodopa/Carbidopa/Entacapone versus Levodopa/Carbidopa/Opicapone in Parkinson's Disease Patients
    Mueller, Thomas
    Schlegel, Eugen
    Zingler, Stephanie
    Thiede, Hans Michael
    CELLS, 2022, 11 (09)
12345